Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 1
2012 3
2013 2
2014 9
2015 7
2016 3
2017 6
2018 6
2019 2
2020 10
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.
Takei H, Luiz Coelho-Silva J, Tavares Leal C, Queiroz Arantes Rocha A, Mantello Bianco T, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima K, Agostinho Machado-Neto J, Kobayashi SS, Lobo de Figueiredo-Pontes L. Takei H, et al. Among authors: mullally a. Cancer Sci. 2021 Nov 22. doi: 10.1111/cas.15210. Online ahead of print. Cancer Sci. 2021. PMID: 34808021 Free article.
Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses.
Knudsen TA, Skov V, Stevenson KE, Werner L, Duke W, Laurore C, Gibson CJ, Nag A, Thorner AR, Wollison B, Hansen DL, Ellervik C, El Fassi D, de Stricker K, Ocias LF, Brabrand M, Bjerrum OW, Overgaard U, Frederiksen M, Kristensen T, Kruse T, Thomassen M, Mourits-Andersen T, Severinsen MT, Stentoft J, Starklint J, Neuberg D, Kjaer L, Larsen TS, Hasselbalch HC, Lindsley RC, Mullally A. Knudsen TA, et al. Among authors: mullally a. Blood Adv. 2021 Sep 10:bloodadvances.2021004856. doi: 10.1182/bloodadvances.2021004856. Online ahead of print. Blood Adv. 2021. PMID: 34507355 Free article.
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms.
Van Egeren D, Escabi J, Nguyen M, Liu S, Reilly CR, Patel S, Kamaz B, Kalyva M, DeAngelo DJ, Galinsky I, Wadleigh M, Winer ES, Luskin MR, Stone RM, Garcia JS, Hobbs GS, Camargo FD, Michor F, Mullally A, Cortes-Ciriano I, Hormoz S. Van Egeren D, et al. Among authors: mullally a. Cell Stem Cell. 2021 Mar 4;28(3):514-523.e9. doi: 10.1016/j.stem.2021.02.001. Epub 2021 Feb 22. Cell Stem Cell. 2021. PMID: 33621486 Free PMC article.
COVID-19 and myeloproliferative neoplasms: some considerations.
Kamaz B, Mullally A. Kamaz B, et al. Among authors: mullally a. Leukemia. 2021 Jan;35(1):279-281. doi: 10.1038/s41375-020-01070-8. Epub 2020 Oct 26. Leukemia. 2021. PMID: 33106624 Free PMC article. No abstract available.
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Jayavelu AK, Schnöder TM, Perner F, Herzog C, Meiler A, Krishnamoorthy G, Huber N, Mohr J, Edelmann-Stephan B, Austin R, Brandt S, Palandri F, Schröder N, Isermann B, Edlich F, Sinha AU, Ungelenk M, Hübner CA, Zeiser R, Rahmig S, Waskow C, Coldham I, Ernst T, Hochhaus A, Jilg S, Jost PJ, Mullally A, Bullinger L, Mertens PR, Lane SW, Mann M, Heidel FH. Jayavelu AK, et al. Among authors: mullally a. Nature. 2020 Dec;588(7836):157-163. doi: 10.1038/s41586-020-2968-3. Epub 2020 Nov 25. Nature. 2020. PMID: 33239784
49 results